JPRN-UMIN000010963
Completed
Phase 1
Phase I study of combination chemotherapy with nab-paclitaxel and Nedaplatin as first-line treatment in patients with advanced squamous cell lung cancer. - Phase I study of combination chemotherapy with nab-paclitaxel and Nedaplatin as first-line treatment in patients with advanced squamous cell lung cancer.
Kitasato University School of Medicine Department of Respiratory Medicine0 sites16 target enrollmentJune 17, 2013
ConditionsSquamous cell lung cancer
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Squamous cell lung cancer
- Sponsor
- Kitasato University School of Medicine Department of Respiratory Medicine
- Enrollment
- 16
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) Severe infection. 2\) Severe complications. 3\) Uncontrollable pleural or pericardial effusion or ascites. 4\) Superior vena cava syndrome. 5\) Simultaneous or metachronous double cancers. 6\) Symptomatic brain metastases. 7\) Prior radiotherapy for primary tumor. 8\) Radiotherapy other than primary tumor within 2 weeks. 9\) A history of serious drug allergy or severe allergic reaction with albumin. 10\) Psycologic illness
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 1
Phase I/II trial of combined chemotherapy of Nab-paclitaxel, S-1, and Oxaliplatin for gastric cancer patients with peritoneal metastasis (NSOX study)gastric cancer with peritoneal metastasisJPRN-UMIN000030909Wakayama Medical University, School of Medicine35
Completed
Phase 1
Phase I/II study of combination chemotherapy with Paclitaxel and TS-1 and Cisplatin for unresectable/ recurrent gastric cancerunresectable or recurrent gastric cancerJPRN-UMIN000004729School of Medicine, Keio University40
Completed
Phase 1
Phase I-II study of combination chemotherapy with Irinotecan and Gemcitabine for clear cell or mucinous ovarian cancerClear cell or mucinous ovarian cancerJPRN-UMIN000005952Osaka university, faculty of medicine40
Completed
Phase 1
A phase I study of the combination chemotherapy of IRISOX (irinotecan/S-1/oxaliplatin) in gemcitabine-refractory pancreatic cancergemcitabine-refractory pancreatic cancerJPRN-UMIN000022964Kitasato University School of Medicine12
Completed
Phase 2
A Phase II study of combination chemotherapy with TS-1 and Trastuzumab for patients with HER2 positive advanced or recurrent gastric cancer.advanced or recurrent gastric cancerJPRN-UMIN000008220Osaka medical center for cancer and cardiovascular diseases20